Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 3
1947 4
1950 1
1951 3
1952 3
1953 1
1955 3
1958 2
1959 2
1960 2
1961 2
1962 2
1963 7
1964 5
1965 13
1966 10
1967 15
1968 6
1969 14
1970 11
1971 12
1972 6
1973 14
1974 9
1975 14
1976 14
1977 18
1978 19
1979 24
1980 28
1981 21
1982 26
1983 27
1984 24
1985 45
1986 30
1987 21
1988 22
1989 39
1990 37
1991 29
1992 37
1993 42
1994 40
1995 50
1996 47
1997 58
1998 50
1999 55
2000 52
2001 66
2002 74
2003 74
2004 82
2005 83
2006 117
2007 125
2008 157
2009 158
2010 183
2011 230
2012 235
2013 232
2014 275
2015 291
2016 294
2017 297
2018 286
2019 300
2020 406
2021 526
2022 485
2023 470
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

5,814 results

Results by year

Filters applied: . Clear all
Page 1
Epsin Nanotherapy Regulates Cholesterol Transport to Fortify Atheroma Regression.
Cui K, Gao X, Wang B, Wu H, Arulsamy K, Dong Y, Xiao Y, Jiang X, Malovichko MV, Li K, Peng Q, Lu YW, Zhu B, Zheng R, Wong S, Cowan DB, Linton M, Srivastava S, Shi J, Chen K, Chen H. Cui K, et al. Among authors: srivastava s. Circ Res. 2023 Jan 6;132(1):e22-e42. doi: 10.1161/CIRCRESAHA.122.321723. Epub 2022 Nov 29. Circ Res. 2023. PMID: 36444722 Free article.
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy.
Bhatia V, Kamat NV, Pariva TE, Wu LT, Tsao A, Sasaki K, Sun H, Javier G, Nutt S, Coleman I, Hitchcock L, Zhang A, Rudoy D, Gulati R, Patel RA, Roudier MP, True LD, Srivastava S, Morrissey CM, Haffner MC, Nelson PS, Priceman SJ, Ishihara J, Lee JK. Bhatia V, et al. Among authors: srivastava s. Nat Commun. 2023 Apr 11;14(1):2041. doi: 10.1038/s41467-023-37874-2. Nat Commun. 2023. PMID: 37041154 Free PMC article.
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts.
Strand SH, Rivero-Gutiérrez B, Houlahan KE, Seoane JA, King LM, Risom T, Simpson LA, Vennam S, Khan A, Cisneros L, Hardman T, Harmon B, Couch F, Gallagher K, Kilgore M, Wei S, DeMichele A, King T, McAuliffe PF, Nangia J, Lee J, Tseng J, Storniolo AM, Thompson AM, Gupta GP, Burns R, Veis DJ, DeSchryver K, Zhu C, Matusiak M, Wang J, Zhu SX, Tappenden J, Ding DY, Zhang D, Luo J, Jiang S, Varma S, Anderson L, Straub C, Srivastava S, Curtis C, Tibshirani R, Angelo RM, Hall A, Owzar K, Polyak K, Maley C, Marks JR, Colditz GA, Hwang ES, West RB. Strand SH, et al. Among authors: srivastava s. Cancer Cell. 2022 Dec 12;40(12):1521-1536.e7. doi: 10.1016/j.ccell.2022.10.021. Epub 2022 Nov 17. Cancer Cell. 2022. PMID: 36400020 Free article.
CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target.
Le Q, Hadland B, Smith JL, Leonti A, Huang BJ, Ries R, Hylkema TA, Castro S, Tang TT, McKay CN, Perkins L, Pardo L, Sarthy J, Beckman AK, Williams R, Idemmili R, Furlan S, Ishida T, Call L, Srivastava S, Loeb AM, Milano F, Imren S, Morris SM, Pakiam F, Olson JM, Loken MR, Brodersen L, Riddell SR, Tarlock K, Bernstein ID, Loeb KR, Meshinchi S. Le Q, et al. Among authors: srivastava s. J Clin Invest. 2022 Nov 15;132(22):e157101. doi: 10.1172/JCI157101. J Clin Invest. 2022. PMID: 36136600 Free PMC article.
Reply by Authors.
Tram M, Zipkin J, Srivastava S, Welliver C. Tram M, et al. Among authors: srivastava s. Urol Pract. 2023 May;10(3):259-260. doi: 10.1097/UPJ.0000000000000397.02. Epub 2023 Apr 4. Urol Pract. 2023. PMID: 37103513 No abstract available.
PreCancer Atlas: Present and Future.
Srivastava S, Wagner PD, Hughes SK, Ghosh S. Srivastava S, et al. Cancer Prev Res (Phila). 2023 Jul 5;16(7):379-384. doi: 10.1158/1940-6207.CAPR-22-0435. Cancer Prev Res (Phila). 2023. PMID: 37403657 Review.
Microtubule acetylation dyshomeostasis in Parkinson's disease.
Naren P, Samim KS, Tryphena KP, Vora LK, Srivastava S, Singh SB, Khatri DK. Naren P, et al. Among authors: srivastava s. Transl Neurodegener. 2023 May 8;12(1):20. doi: 10.1186/s40035-023-00354-0. Transl Neurodegener. 2023. PMID: 37150812 Free PMC article. Review.
Emerging application of nanotechnology for mankind.
Kanaoujiya R, Saroj SK, Rajput VD, Alimuddin, Srivastava S, Minkina T, Igwegbe CA, Singh M, Kumar A. Kanaoujiya R, et al. Among authors: srivastava s. Emergent Mater. 2023;6(2):439-452. doi: 10.1007/s42247-023-00461-8. Epub 2023 Jan 31. Emergent Mater. 2023. PMID: 36743193 Free PMC article. Review.
Vaccines against Tuberculosis: Where Are We Now?
Srivastava S, Dey S, Mukhopadhyay S. Srivastava S, et al. Vaccines (Basel). 2023 May 22;11(5):1013. doi: 10.3390/vaccines11051013. Vaccines (Basel). 2023. PMID: 37243117 Free PMC article. Review.
5,814 results